L7 | Customers
Agriculture and Agri-Food Canada supports the Canadian agriculture and agri-food sector through initiatives that promote innovation and competitiveness.
ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines and microorganisms.
Benson Hill moves food forward with the CropOS® platform, a cutting-edge food innovation engine that combines data science and machine learning with biology and genetics.
Biobot Analytics is a global leader in wastewater intelligence, founded with the goal of transforming wastewater infrastructure into real-time public health observatories. Having worked at more than 1,000 locations across all 50 US states and several countries, Biobot produces actionable information from wastewater to improve the health of communities around the world.
Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need.
Cellipont Bioservices is a privately-held cell therapy CDMO based near San Diego, California with more than 15 years of experience in the development and small-to-large batch manufacturing of cell therapies. Our team has deep technical expertise and has been recognized by customers and partners for its ability to productively grow challenging cell types. Our culture is customer-centric with a focus on partnering, flexibility and responsiveness.
Cibus is a leading agricultural biotechnology company that uses gene editing to breed plants with new genetic traits that make them healthier and better able to thrive in their changing environments.
CReATe stands for Canadian Reproductive Assisted Technology. Headquartered in Toronto, Ontario, CReATe is internationally renowned for their specialized fertility services, ground-breaking research, and commitment to provide personalized, comprehensive, and cutting-edge care for every fertility journey.
The Contamination Source Identification's mission is to contribute meaningfully to the delivery of effective patient care by providing physicians with accurate active pathogen identification results to enable confident disease diagnosis and targeted treatment decisions.
Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy.
The Genome Engineering and IPSC Center (GEiC) facilitate functional genomic studies through the use of patient-derived iPSCs and the generation of modified cells and organisms using genome editing technologies.
GeneDx, Inc. is a global leader in genomics, providing testing to patients and their families from more than 55 countries. GeneDx offers a world-renowned clinical genomics program with particular expertise in rare and ultra-rare genetic disorders.
Gradalis is a late-stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
The Genome Technology Access Center at the McDonnell Genome Institute (part of Washington University in St. Louis) facilitates functional genomic studies.
Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis and management.
Nobell Foods creates key dairy proteins, including casein, from high-quality soybeans, enabling the brand to make cheeses that taste, smell, melt, stretch, and even age like those made from animals, and challenging the way we talk about, think about, and eat cheese.
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, their diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors, and improve healthcare management.
Rady Children’s Institute for Genomic Medicine® is transforming neonatal and pediatric healthcare by harnessing the power of Rapid Precision Medicine™ to improve the lives of children and families facing rare genetic disease.
Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, offers the most advanced cancer treatment options including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures.
The Jackson Laboratory is an independent, nonprofit biomedical research institution founded in 1929 in Bar Harbor, Maine, which mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
Think Bioscience is reimagining synthetic biology by using living systems to guide the design and assembly of better medicines. The unique approach to drug discovery combines applied microbiology, enzymology, and computational science to develop small-molecule therapeutics against elusive targets.
Vernal Biosciences provides mRNA and LNP-mRNA manufacturing services to democratize the use of mRNA for all use cases ranging from drug discovery to clinical development across all use cases such as gene editing and regulation, cellular programming, vaccines, mRNA replacement, oncology, autoimmune, and protein degradation.
L7|ESP is an adaptable and customizable platform that streamlines process execution, provides a complete chain of custody from sample to report, and enables management of complex workflows.
Simon Hughes, Associate Director, CDx Assay Development, QIAGEN
L7 plays a key role in our end-to-end automation of the patient journey - from order to clinical report.
Dr. Stephen Kingsmore, President/CEO, Rady Children's Institute for Genomic Medicine
L7|ESP provides a single platform to assure both control and compliance, while providing a seamless transfer of clinical operations to manufacturing operations.
Ernie Bognar, Chief Operations Officer, Gradalis, Inc.